6 patent families
• Portfolio of 62 granted patents with 8
patent applications under examination
Covers
neurodegenerative diseases
specifically Amyotrophic Lateral
Sclerosis, Alzheimer’s Disease,
Parkinson’s Disease & Huntington’s
Disease
Long Runway
Key patent granted in the US
(US 9,790,176) for “Compounds
For The Treatment of mTOR Pathway
Related Diseases”.
• Projected expiry for these patents
is August 2033.
clawing back the lost ground ,,, value lost for the FDA query is circa $38m , so making up ground swiftly already today NZT
Ann: Neurizon to Present Latest Results and Key Updates, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
-0.010(5.88%) |
Mkt cap ! $81.23M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 16.0¢ | $77.81K | 468.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 161760 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 11040 | 2 |
View Market Depth
| Last trade - 15.02pm 30/07/2025 (20 minute delay) ? |
| NUZ (ASX) Chart |